KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Liabilities and Shareholders Equity for 11 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 5.97% year-over-year to $2.0 billion, compared with a TTM value of $5.6 billion through Dec 2025, down 3.28%, and an annual FY2025 reading of $2.0 billion, down 5.97% over the prior year.
  • Liabilities and Shareholders Equity was $2.0 billion for Q4 2025 at Medpace Holdings, up from $1.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.1 billion in Q4 2024 and bottomed at $1.3 billion in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2021.
  • The sharpest move saw Liabilities and Shareholders Equity dropped 18.52% in 2022, then skyrocketed 36.47% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $1.7 billion in 2021, then decreased by 18.52% to $1.4 billion in 2022, then rose by 22.5% to $1.7 billion in 2023, then rose by 26.8% to $2.1 billion in 2024, then dropped by 5.97% to $2.0 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for MEDP at $2.0 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.9 billion in Q1 2025.